Financials
- Market Capitalization 22.12 M
- Employee 19
- Founded 2015
- CEO N/A
- Website www.abvcpharma.com
- Headquarter Nevada, United States
- FIGI BBG000Q844Z2
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-5.46
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4531 | ALLR Allarity Therapeutics, Inc. - Common stock | 1.41 USD | +2.17% | -0.70% | +17.50% | -8.44% | 22.43 M USD | ||
| 4535 | DYAI Dyadic International, Inc. - Common Stock | 0.61 USD | -4.69% | -14.08% | -42.99% | -32.97% | 22.23 M USD | ||
| 4540 | KZIA Kazia Therapeutics Limited - American Depositary Shares | 13.58 USD | -19.64% | +1.65% | +7.01% | +132.14% | 21.98 M USD | ||
| 4546 | LGVN Longeveron Inc. - Class A Common stock | 6.72 USD | -1.18% | +690.59% | +1020.00% | +1076.26% | 21.42 M USD |